Capstone Investment Advisors, LLC Bausch Health Companies Inc. Transaction History

Capstone Investment Advisors, LLC

  • $30.4 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
BUY
$6.53 - $8.23 $158,535 - $199,807
24,278 New
24,278 $194,000
Q2 2023

Aug 10, 2023
BUY
$5.72 - $8.8 $57,491 - $88,448
10,051 New
10,051 $80,000
Q4 2020

Feb 16, 2021
SELL
$15.31 - $21.12 $383,163 - $528,570
-25,027 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$14.88 - $20.13 $372,401 - $503,793
25,027 New
25,027 $389,000
Q4 2019

Feb 14, 2020
SELL
$18.89 - $31.89 $114,492 - $193,285
-6,061 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$20.88 - $25.66 $126,553 - $155,525
6,061 New
6,061 $132,000

Others Institutions Holding BHC

# of Institutions
254
Shares Held
253M
Call Options Held
5.53M
Put Options Held
16.5M
View Full List

About Bausch Health Companies Inc.

BHC Quotes by TradingView
  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email